The Cognition-Kidney Disease Connection: Lessons From Population-Based Studies in the United States

American Journal of Kidney Diseases

Volumn 52, Issue 2, 2008, Pages 201-204

  Weiner, Daniel E ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL INDICATOR; COGNITIVE DEFECT; COMORBIDITY; DEMENTIA; DISEASE ASSOCIATION; EDITORIAL; HUMAN; KIDNEY DISEASE; POPULATION BASED CASE CONTROL STUDY; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGED; COGNITION DISORDERS; HUMANS; INCIDENCE; KIDNEY DISEASES; MIDDLE AGED; POPULATION SURVEILLANCE; RISK FACTORS; UNITED STATES;

EID: 47149088867     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.05.003     Document Type: Editorial

References (28)

1. Castro A, Coresh J: CKD surveillance using laboratory data and population-based surveys (NHANES). Am J Kidney Dis (in press)
2. Plassman B.L., Langa K.M., Fisher G.G., et al. Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med 148 (2008) 427-434
3. Barzilay J.I., Fitzpatrick A.L., Luchsinger J., et al. Albuminuria and dementia in the elderly: A community study. Am J Kidney Dis 52 (2008) 216-226
4. Kurella Tamura M., Wadley V., Yaffe K., et al. Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis 52 (2008) 227-234
5. Gauthier S., Reisberg B., Zaudig M., et al. Mild cognitive impairment. Lancet 367 (2006) 1262-1270
6. Chapman D.P., Williams S.M., Strine T.W., Anda R.F., and Moore M.J. Dementia and its implications for public health. Prev Chronic Dis 3 (2006) A34
7. O'Brien J.T., Erkinjuntti T., Reisberg B., et al. Vascular cognitive impairment. Lancet Neurol 2 (2003) 89-98
8. Emery V.O., Gillie E.X., and Smith J.A. Interface between vascular dementia and Alzheimer syndrome. Nosologic redefinition. Ann N Y Acad Sci 903 (2000) 229-238
9. de Leeuw F.E., De Groot J.C., Oudkerk M., et al. Aortic atherosclerosis at middle age predicts cerebral white matter lesions in the elderly. Stroke 31 (2000) 425-429
10. de Leeuw F.E., Richard F., de Groot J.C., et al. Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke 35 (2004) 1057-1060
11. Weiner D.E., Tabatabai S., Tighiouart H., et al. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis 48 (2006) 392-401
12. Weiner D.E., Tighiouart H., Elsayed E.F., et al. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol 50 (2007) 217-224
13. Knopman D., Boland L.L., Mosley T., et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 56 (2001) 42-48
14. Kalmijn S., Foley D., White L., et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 20 (2000) 2255-2260
15. Curb J.D., Rodriguez B.L., Abbott R.D., et al. Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology 52 (1999) 971-975
16. Petrovitch H., White L., Masaki K.H., et al. Influence of myocardial infarction, coronary artery bypass surgery, and stroke on cognitive impairment in late life. Am J Cardiol 81 (1998) 1017-1021
17. Ross G.W., Petrovitch H., White L.R., et al. Characterization of risk factors for vascular dementia: the Honolulu-Asia Aging Study. Neurology 53 (1999) 337-343
18. Morris M.C., Scherr P.A., Hebert L.E., Glynn R.J., Bennett D.A., and Evans D.A. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol 58 (2001) 1640-1646
19. Posner H.B., Tang M.X., Luchsinger J., Lantigua R., Stern Y., and Mayeux R. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 58 (2002) 1175-1181
20. in't Veld B.A., Ruitenberg A., Hofman A., Stricker B.H., and Breteler M.M. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging 22 (2001) 407-412
21. Kivipelto M., Helkala E.L., Laakso M.P., et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322 (2001) 1447-1451
22. Skoog I., Lernfelt B., Landahl S., et al. 15-year longitudinal study of blood pressure and dementia. Lancet 347 (1996) 1141-1145
23. Schmidt R., Schmidt H., Curb J.D., Masaki K., White L.R., and Launer L.J. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 52 (2002) 168-174
24. Seshadri S., Beiser A., Selhub J., et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346 (2002) 476-483
25. Seliger S.L., Siscovick D.S., Stehman-Breen C.O., et al. Moderate renal impairment and risk of dementia among older adults: The Cardiovascular Health Cognition Study. J Am Soc Nephrol 15 (2004) 1904-1911
26. Kurella M., Chertow G.M., Fried L.F., et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol 16 (2005) 2127-2133
27. Kuo H.K., Lin L.Y., and Yu Y.H. Microalbuminuria is a negative correlate for cognitive function in older adults with peripheral arterial disease: results from the U.S. National Health and Nutrition Examination Survey 1999-2002. J Intern Med 262 (2007) 562-570
28. Hailpern S.M., Melamed M.L., Cohen H.W., and Hostetter T.H. Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 18 (2007) 2205-2213